10 Novartis finance leaders
Chief financial officer, executive finance director and global head of finance are among the roles held by these ten Novartis finance leaders. A reader can learn how finance leaders work at Novartis from people who have held the role.
Professionals to explore
Adriano Machado
LinkedInExperience: Group M&A – Executive Finance Director · Novartis
Adriano Machado has been Group M&A – Executive Finance Director at Novartis since May 2022, based in East Hanover, New Jersey, according to the profile. Adriano Machado also held the roles Country CFO - Mexico (2019–2022), Regional BPA Head - Latin America and Canada (2015–2019), Global BPA (2013–2015) and Head of BPA - Chile (2011–2013) at the company.
Alexandre Tavares
LinkedInExperience: Global Head of Finance, International · Novartis
Alexandre Tavares has been Global Head of Finance, International at Novartis since September 2022, where, according to the profile, Alexandre Tavares provides finance leadership and business partnering to global commercial, medical and access teams outside the US. Alexandre Tavares also held the roles Executive Director, Business Development and M&A Finance (2022) and Head Business Development and Finance, Asia-Pacific Middle East & Africa (2018–2022) at the company.
Hitendra Kapadia
LinkedInExperience: Director, BD&L Finance · Novartis
Hitendra Kapadia has been Director, BD&L Finance at Novartis since November 2024, where, according to the profile, Hitendra Kapadia provides decision support for prospective M&A and BD&L activities for the Biomedical Research division. Hitendra Kapadia also held the roles Director Of Financial Planning - US Oncology Rare Diseases CAR-T Cellular Therapy (2015–2017) and Director Of Financial Planning - Global Oncology Business Unit (2010–2015) at the company.
Jiham Cha
LinkedInExperience: Executive Finance Director · Novartis
Jiham Cha has been Executive Finance Director at Novartis since September 2011; the profile lists the role Executive Finance Director, Novartis APMA (Asia Pacific Middle East Africa) Region with the year 2023, and work on a new commercial access model using private health insurance, fintech and healthtech. Jiham Cha was also Financial Reporting Lead Internal Audit FMP at GE (2003–2011).
Mario Fleig
LinkedInExperience: Strategic Finance Head, Novartis Group Finance · Novartis
Mario Fleig has been Strategic Finance Head, Novartis Group Finance at Novartis since April 2022. Mario Fleig also held the roles Director of Finance, Global Pharma BD&L and M&A (2018–2022), Technical Accounting, NBS FRA Operations / Global GDD Lead (2016–2018) and Head of Financial Accounting, Technical Operations (2014–2016) at the company, and was Accounting and External Reporting Manager at Roche (2016).
Mukul Mehta
LinkedInExperience: Chief Financial Officer, Member of the Executive Committee · Novartis
Mukul Mehta has been Chief Financial Officer, Member of the Executive Committee at Novartis since March 2026, and also Head of BPA, Digital Finance and Tax there since March 2025. Mukul Mehta also held the roles CFO International (2022–2025), Chief Financial Officer, Novartis Pharmaceuticals (2019–2022) and CFO, Novartis Business Services (2018–2019) at the company.
Nigel Trotman
LinkedInExperience: CFO Development · Novartis
Nigel Trotman has been CFO Development at Novartis since August 2022, a role the profile places in Basel at C-Level in the Finance & Accounting department. Nigel Trotman also held the roles CFO, Business Services (2022), CFO, Asia Pacific Middle East (2019–2021), Head of Group Planning and Management Reporting (2016–2019) and Head of Group Business Planning (2015–2016) at the company.
Paulina Azpiazu
LinkedInExperience: Head Finance Development US · Novartis
Paulina Azpiazu has been Head Finance Development US at Novartis since September 2025. Paulina Azpiazu also held the roles US LDC (Lean Digital Core, SAP TO S4Hana) & Reporting and Analytics Lead (2024–2025), Director Finance Business Services (US) (2022–2024), Finance Head for Shared Service Hub MX, Latam & Canada (2019–2022) and Business Planning and Analysis Head - Pharma Division (2017–2019) at the company.
Rodrigo Bolzan Carneiro
LinkedInExperience: Internacional BPA Finance Director · Novartis
Rodrigo Bolzan Carneiro has been Internacional BPA Finance Director at Novartis since February 2025, a role the profile places in Basel at Director level. Rodrigo Bolzan Carneiro also held the roles Brazil IM BPA FP&A Head - Finance Director (2022–2025), LACan FLT Strategic Assistant (2023–2024) and Portugal Oncology Finance Head (CFO) (2021–2022) at the company.
Simon Degen
LinkedInExperience: Finance Director Global Health · Novartis
Simon Degen has been Finance Director Global Health at Novartis since April 2022, where, according to the profile, Simon Degen is responsible for financial steering, performance management and strategic planning of global access and health system programs. Simon Degen also held the roles Head Finance Eastern & Southern Africa (ad interim) (2024) and Head FP&A Global Health & Sustainability (ad interim) (2023) at the company.
Choose the right perspective
Pick the person whose finance area, such as group finance, M&A and BD&L finance, development finance or a region's commercial finance, matches the decision you are working on. Weigh their scope, since a business unit finance head and a group CFO will describe the same trade-off differently.
Questions to take into the conversation
- 01Which finance decisions take most of your time in your current role?
- 02How do you decide where to push back on a business plan and where to support it?
- 03What changed in how you work when your finance scope grew to a larger region or function?
Reaching Novartis finance leaders
How can I contact one of these Novartis finance leaders?
Pick one of the 10 people on this page and choose "Book a paid call", or describe your project to find others. You offer a fee for a 15-minute call or a written answer, Instant Expert finds the person's work email and sends the invitation, and they decide whether to accept. The list covers 1 company: Novartis, based on profile data retrieved on October 17, 2026. Being listed here doesn't mean someone has agreed to take calls.
How much does it cost to reach Novartis finance leaders?
You choose the offer, starting at $5 per person. The offer is what the person receives, and Instant Expert's fee is added on top, so a $100 offer costs you $125. The fee is 20% of what you pay. You're charged only when the person books the call or sends the answer.
What if they don't reply?
You pay nothing. Instant Expert sends follow-up reminders, and if the person hasn't booked or answered within 7 days, the request expires and any hold on your card is released. You can invite several of the 10 people on this list at once and cap your total spend, so you pay only for the ones who accept.
Can an AI agent ask one of these Novartis finance leaders a question?
Yes. An agent with a USDC wallet on Base can ask one question without an Instant Expert account. It names the person, for example by the LinkedIn URL on this page, and pays per ask over x402 (HTTP 402). The person answers in writing or by voice note, and if nobody answers within 7 days, the payment goes back to the wallet automatically. Claude and ChatGPT can do the same through the Instant Expert connector: setup is at /docs/mcp for Claude and /docs/chatgpt for ChatGPT. x402 docs
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.
Request a correction or removal